AI-generated research brief — verify at source
Adding tDCS to CBT Accelerates Pain and Functional Recovery in Veterans with Chronic Low Back Pain
In a double-blind randomized controlled trial of 115 U.S. Veterans with chronic low back pain and prescription opioid misuse, those receiving real transcranial direct current stimulation (tDCS) during cognitive behavioral therapy showed significantly steeper declines in both pain and functional impairment compared to those receiving sham stimulation. Opioid misuse fell in both groups over time, but without additional benefit attributable to the active tDCS component.
What Was Studied
The trial examined whether pairing tDCS — a low-risk, non-invasive form of brain stimulation — with Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) could improve pain intensity, functional impairment, and opioid misuse beyond what CBT-CP alone provides. This question is clinically relevant because CBT-CP, the VA’s recommended nonpharmacologic treatment for this population, frequently yields only modest patient-level improvements, and effective adjunctive strategies are needed.
How It Was Studied
This registered, double-blind RCT (NCT02483468) enrolled 115 U.S. Veterans diagnosed with chronic low back pain who also reported prescription opioid misuse. Participants were randomly assigned to receive either real or sham tDCS delivered during each of 11 CBT-CP sessions, preserving the behavioral treatment structure across both arms. Outcomes covering pain, functional impairment, and opioid misuse were assessed repeatedly from baseline through a post-treatment follow-up period. Mixed-effects models were applied to capture longitudinal trajectories across study timepoints for each group.
What Was Observed
- Pain declined more steeply in the real tDCS group. Mixed-effects modeling identified a statistically significant time × group interaction for pain, indicating that participants receiving active tDCS experienced a faster rate of pain reduction across the study period compared to those receiving sham stimulation. Specific effect sizes and confidence intervals were not reported in the abstract.
- Functional impairment also improved at an accelerated rate with active tDCS. A parallel significant time × group interaction was observed for functional impairment, with the real tDCS arm again demonstrating a steeper downward trajectory. The authors note that end-of-treatment scores between groups were similar, suggesting the advantage lies in the speed of improvement rather than the final outcome level achieved.
- Opioid misuse decreased in both groups, but tDCS provided no additional benefit on this outcome. Both the real and sham tDCS groups showed statistically significant reductions in opioid misuse over time, indicating that CBT-CP itself was effective in this domain. The addition of tDCS did not produce a further reduction in misuse beyond the behavioral treatment effect.
Why This Matters
Chronic low back pain among Veterans is associated with significant functional impairment and prescription opioid misuse, and the VA’s established behavioral treatment — CBT-CP — leaves meaningful room for improvement in many patients. This trial suggests that tDCS, a low-risk neuromodulation technique, may serve as a practical adjunct by accelerating the rate at which patients gain relief, even if final endpoint scores converge. The authors propose that faster treatment gains could enhance patient engagement and reduce disability burden during the course of behavioral treatment, and that the accelerated improvements in pain and function might carry downstream benefits for opioid-related outcomes over longer timeframes.
How to Read This Result
These findings from a moderately sized single-arm RCT are encouraging, but should be interpreted with caution: specific effect sizes and confidence intervals were not reported in the abstract, the long-term durability of the accelerated gains beyond the study window is unknown, and replication in larger and more diverse samples will be needed before drawing firm conclusions about tDCS as a routine adjunct to behavioral pain treatment.
Limitations
The abstract does not explicitly report study limitations.